NSE filing, NSE: KIRLPNU. Summary written from the filing by ALFA Finder's alert engine.
Kirloskar Pneumatic Company Ltd: key numbers
- Share price
- ₹542.90
- Market cap
- ₹7,056 Cr
- Revenue (annual)
- ₹1,787 Cr
- Net profit (annual)
- ₹256.1 Cr
- P/E (TTM)
- 27.2×Sector 52.2×
- Promoter holding
- 38.80%-0.01% QoQ
- FII holding
- 10.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kirloskar Pneumatic Company Ltd
All →Kirloskar Pneumatic Company Earnings Call Transcript: Key Takeaways
Kirloskar Pneumatic reported a weak Q2 with revenue down YoY due to export and engineering execution delays.
- Call
- Guides 20% growth
Kirloskar Pneumatic Company Partnership
KPCL and Japan's Kobe Steel signed an MoU to jointly explore Oil & Gas opportunities in India and export markets. No contract value or timeline was specified.
Kirloskar Pneumatic Company Investor Presentation: Key Takeaways
H1 FY27 sales Rs 624 Cr (down 4% YoY), EBITDA Rs 103 Cr at 16.2% margin, PAT Rs 74 Cr (up 4%). Order board Rs 2,040 Cr, up 10% since April; Kobe Steel MoU for non-general compressors.
Kirloskar Pneumatic Company Employee Stock Options
Kirloskar Pneumatic allotted 9,700 shares under its employee stock option scheme. No exercise price or consideration is disclosed in the filing.
Kirloskar Pneumatic Company Results Update
KPCL posted Q2 FY27 revenue of ₹320 Cr and PAT of ₹40 Cr. H1 revenue was ₹620 Cr with order book up 10% to ₹2,040 Cr.
Kirloskar Pneumatic Company Q2 FY27 Results: Net Profit ₹40 Cr, Down 8.7% YoY
Kirloskar Pneumatic Company Ltd reported revenue from operations of ₹326.3 Cr (-15.6% YoY) and net profit of ₹40 Cr (-8.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹40 Cr · -8.7% YoY
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date